USFDA 483 Cites Piramal Pharma for Inves
Piramal Pharma’s API unit at Navi Mumbai was issued USFDA Form 483 with six observations
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
